ELAB earnings date and last-quarter result: P/E -0.00. Updated 2026-07-23.
PMGC Holdings (ELAB) Research Hub
PMGC Holdings (ELAB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.61 USD (-3.54%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.00, market cap 0.00B. This hub links to the full technical, earnings and options research available for ELAB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.61 USD (-3.54%) |
| 52-week range | 2.59 USD – 15.1 USD |
| Trend regime | Range |
| 14-day RSI | 18 (Oversold) |
| Trailing P/E | -0.00 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for ELAB
Covered Call on ELAB: how it works, illustrative setup around the real 2.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELAB: how it works, illustrative setup around the real 2.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELAB: how it works, illustrative setup around the real 2.61 USD price, max profit/loss, breakeven and when to use it. Educational.
ELAB technical analysis: range, last 2.61 USD, RSI 18, 52w range 2.59 USD–15.1 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ELAB in?
PMGC Holdings (ELAB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ELAB in an uptrend or downtrend?
As of 2026-10-26, ELAB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELAB's trailing P/E ratio?
ELAB's trailing P/E is -0.00, with a market cap of 0.00B. See the earnings research page for full valuation detail.